Home / NEWS / Top News / Biogen shares surge 38% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

Biogen shares surge 38% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

The medicine, which is marketed under the name Aduhelm, is expected to generate billions of dollars in revenue for the company.

Check Also

Ponzi schemer Madoff earned $710 for almost 3,000 hours of prison work, got ‘not very dependable’ review

Bernie Madoff decreased in prison, where he was serving a 150-year sentence for running the …

Leave a Reply

Your email address will not be published. Required fields are marked *